Endometriosis Knowledgebase


A repository for genes associated with endometriosis

Results


PMID 23334337
Gene Name VEGFC
Condition Endometriosis
Association Associated
Population size 15
Population details 15 (10 peritoneal endometriosis, 5 controls)
Age 26–42 yrs
Sex Female
Infertility type Female infertility
Associated genes VEGF-A, VEGF-B, VEGF-C
Other associated phenotypes Angiogenesis in endometriosis
Vascular endothelial growth factor C is increased in endometrium and promotes endothelial functions, vascular permeability and angiogenesis and growth of endometriosis.

Angiogenesis. 2013 Jul;16(3):541-51. doi: 10.1007/s10456-013-9333-1. Epub 2013

Xu, Hui| Zhang, Tao| Man, Gene Chi Wai| May, Katie E| Becker, Christian M| Davis, Tina N| Kung, Andrew L| Birsner, Amy E| D'Amato, Robert J| Wong, Alice Wai Yee| Wang, Chi Chiu

Department of Obstetrics and Gynaecology, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories, Hong Kong.

Endometriosis is an angiogenesis-dependent disease. Many studies demonstrated inhibition of angiogenesis leads to inhibition of endometriotic growth, however underlying mechanism is still not fully understood. Our previous study suggested vascular endothelial growth factor C (VEGF-C) as a target of anti-angiogenesis therapy for endometriosis. In this study, VEGF-C in endometrium and its role in angiogenesis of endometriosis were studied. Human endometrium were obtained from women with and without endometriosis for molecular studies. VEGF-A, VEGF-B, VEGF-C and VEGF-D mRNA and proteins in eutopic and ectopic endometrium were measured. Human endothelial cells were transfected with VEGF-C siRNA in vitro, effects of VEGF-C on endothelial cell migration, invasion and tube formation were investigated in vitro. Angiogenesis was inhibited in wild type mice, vascular permeability in dermal skin was determined in vivo. Transplanted endometrium were inhibited by VEGF-C siRNA in immunocompromised mice, development, growth and angiogenesis of the experimental endometriosis were compared in vivo. The results showed that VEGF-C mRNA and protein were increased in eutopic and ectopic endometrium of endometriosis patients. VEGF-C siRNA significantly inhibited endothelial cell migration and tube formation. VEGF-C siRNA significantly inhibited development and angiogenesis of the experimental endometriotic lesions in mice. Supplementation and over-expression of VEGF-C significantly reversed the inhibitory effects on the endothelial functions, vascular permeability and endometriotic growth. In conclusion, VEGF-C is increased in endometrium and it promotes endothelial functions, vascular permeability and development of experimental endometriosis. VEGF-C is important for angiogenesis in endometriosis.

Mesh Terms: Analysis of Variance| Animals| Capillary Permeability/*physiology| Cell Movement/drug effects/physiology| Endometriosis/*metabolism| Endometrium/cytology/*metabolism| Endothelial Cells/metabolism/*physiology| Female| Humans| Mice| Neovasculariza